PDK (Pyruvate Dehydrogenase Kinase) inhibitors target the PDK enzyme, which regulates the activity of the pyruvate dehydrogenase complex (PDC) and plays a role in metabolic control and apoptosis. By inhibiting PDK, these compounds shift cellular metabolism from glycolysis towards oxidative phosphorylation, which can induce apoptosis in cancer cells that rely on aerobic glycolysis (Warburg effect) for survival. PDK inhibitors are valuable in cancer metabolism research and therapeutic development. At CymitQuimica, we provide high-quality PDK inhibitors to support your research in cancer metabolism, apoptosis, and cellular bioenergetics.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.